COMBINATION THERAPY WITH ANTI-CD73 ANTIBODIES

Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-CD73 antibody in combination with an immuno-oncology agent, such as an anti-PD-1 antibody.

Saved in:
Bibliographic Details
Main Authors JURE-KUNKEL, Maria, SCHWEIZER, Liang, KORMAN, Alan J, HATCHER, Sandra V, SEGA, Emanuela, HEDRICK, Michael Nathan, LEI, Ming, LONBERG, Nils, SRINIVASAN, Mohan, MYERS, Jr., Joseph E, BARNHART, Bryan C, HUANG, Haichun, ALTURA, Rachel A, YAMNIUK, Aaron P, HUANG, Richard Y, CHEN, Guodong, CORBETT, Martin J, SACK, John S, HILT, Edward J, HENNING, Karla A, ZHANG, Pingping, GOODENOUGH, Angela
Format Patent
LanguageEnglish
Published 19.09.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-CD73 antibody in combination with an immuno-oncology agent, such as an anti-PD-1 antibody.
Bibliography:Application Number: US201716081115